contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


optomed-oyj-optomed-plc-managers-transactions-myllyla-2

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Optomed is a medical technology company. The company conducts research and development of specialized eye cameras. Development takes place of both hardware and software that is resold under different brands. The company operates worldwide, with the largest presence in the Nordic market. The customers consist of research institutes and hospitals. Optomed is headquartered in Oulu.

linkedin.com              AEYE Health on LinkedIn: World Diabetes Day: The Startups Improving Diabetes...    🎉 Excited to share that AEYE Health has been featured in TechRound’s article, "World Diabetes Day: The Startups Improving Diabetes Care"!  We’re honored to be…

linkedin.com              Optomed Plc on LinkedIn: #optomedaurora #optomed #epomec #screening #ai...    Optomed is heading to EPOMEC in Dubai from December 5-7.  We are thrilled to showcase #OptomedAurora with AI integration, designed to provide retinal screening…                             Ja messua pukkaa… tällä kertaa Dubai. Nyt on tekemisen meininkiä. Mites se menikään; ensin tulee työ ja sitten?

Tämä kommentti kertoo paljon: Mallika Kapur • 3rd+ CEO at NextGen eSolutions (P) Ltd.  ](Mallika Kapur - Aimil Ltd. | LinkedIn) Excited to be a part of this event with you Petri Huhtinen. OCI India, thank you for organising this - there is a burning need to screen for Diabetic Retinopathy, and soon.

linkedin.com              Petri Huhtinen on LinkedIn: #diabeticretinopathy #screening...    Thank you Dr. Mallika Kapur and the team for giving me this opportunity to speak about #diabeticretinopathy and #screening without forgetting…                             And meanwhile in India

linkedin.com              Optomed US on LinkedIn: #optomedus #aeyehealth #californiacareforce...    We’re thrilled to have partnered with California CareForce at their recent free healthcare clinic in Fresno, CA! Optomed’s Aurora AEYE handheld fundus camera…

I am excited to announce our latest pilot implementation with Prestige Medical Group, Georgia’s leading primary care practice! This partnership marks another step forward in our mission to deliver a Human+AI solution that provides the best care to #diabetic patients. These patients deserve nothing less than quality care delivered at their convenience and comfort.                   linkedin.com              Awais Bajwa on LinkedIn: #diabetic #blindness #ai #blindnessprevention...    I am excited to announce our latest pilot implementation with Prestige Medical Group, Georgia's leading primary care practice!  This partnership marks another…                                               Prestige Medical Group              Who is Prestige - Prestige Medical Group    [vc_row type=”full_width_background” full_screen_row_position=”middle” column_margin=”default” equal_height=”yes” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default” bg_color=”#224162″ scene_position=”center”...         Est. reading time: 2 minutes

Eiköhän tuolla varastossa ole normaalisti ~1kvartaalin menekkiä vastaava inventaario Aurora IQ:ta, jotta varaston arvo ei nouse liikaaa. Epäilemättä tuo viimeisin isompi tilaus ei tullut “puskista” vaan sitä osattiin odottaa ja täydennystilaus varastoon on tehty jo hyvissä ajoin. Todnäk varasto on nyt ja jatkossa vielä enemmän Aurora AEYE:hin painottuva.

Optomed

Optomed Plc - Managers' Transactions - 12 August 2024 at 12.00 EETOptomed Plc - Managers' transactions - Myllylä____________________________________________Person subject to the notification...

Optomed Plc - Managers' Transactions - 12 August 2024 at 12.00 EETOptomed Plc - Managers' transactions - Myllylä____________________________________________Person subject to the notification requirementName: Markku MyllyläPosition: Other senior managerIssuer: Optomed OyjLEI: 7437009IVYWGEE4S7B77Notification type: INITIAL NOTIFICATIONReference number: 74101/4/4____________________________________________Transaction date: 2024-08-09Outside a trading venueInstrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENTName of the instrument: Optomed Oyj:n optio-oikeus 2018 CNature of transaction: DISPOSAL(X) Linked to stock option programmeTransaction details(1): Volume: 60000 Unit price: 1.2756 EURAggregated transactions (1):Volume: 60000 Volume weighted average price: 1.2756 EUR

Stay up to date with our newsletter